MICHELLE CAFARO: Open Payments
NPI 1619205655 · LOUDONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 32 payments from 20 companies in 2025. Trend: 2023 $1,028 · 2024 $1,062 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $149 |
| ABBVIE INC. | 3 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Indivior Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
Products named: VOQUEZNA, REXULTI, GEMTESA, SUBLOCADE, ZEPBOUND, GARDASIL 9, QULIPTA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
